Bordetella pertussis and parapertussis DNA, Nucleic Acid Amplification, Nasopharyngeal Swab




Test Mnemonic

BORAMP

CPT Codes

  • 87798 - QTY (2)

LOINC ®

43913-3

Aliases

  • Pertussis
  • Whooping Cough

Performing Laboratory

Cleveland Clinic Laboratories

FDA Category

In Vitro Diagnostic


Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
2 - 3 mLNasopharyngeal swabSwab in Universal Transport Media (UTM) RefrigeratedAcceptable specimen types include nasopharyngeal samples collected using flocked swabs in universal transport medium (UTM) or an equivalent viral transport medium. Example accepted collection kits include Oracle #1063581/1035694, Diagnostic Hybrids #402C/403C. Dry swabs, lower respiratory tract specimens (bronchoalveolar lavage, bronchial washings) or other upper respiratory specimens (sputum, throat swabs) will be rejected. Calcium-alginate swabs are not acceptable.

Stability

Environmental Condition Description
RefrigeratedSpecimens are stable up to 97 hours at 2-8C before testing.
AmbientSpecimens are stable up to 49 hours at 15-30C.
FrozenSpecimens are stable at up to 5 months at -70C.

Days Performed

7 days a week

Turnaround Time

1 - 3 days

Methodology

Name Description
Amplification Detection 
Molecular 
Other 

Reference Range

Special Info

This test should not be used as a test of cure to monitor response to therapy.

Clinical Info

Symptoms of pertussis include coughing, sneezing, and runny nose. Within 1-2 weeks a paroxysmal cough followed by a "whoop" sound in infants and children or persistent cough in adolescents or adults develops. Testing should be performed within 4 weeks of cough onset.

Clinical Limitation

The Solana Bordetella Complete Assay is an HDA-based duplex assay that targets the IS481 and IS1001 sequence of Bordetella pertussis (BP) and Bordetella parapertussis (BPP) genomes, respectively. This sequence may also be found in other species of Bordetella. B. holmesii may cause clinical illness similar to B. pertussis and mixed outbreaks have been reported. B. bronchiseptica is a rare cause of human infection. Additional testing should be performed if needed to differentiate B. pertussis from B. holmesii.